Automated platform works alongside existing perinatal systems to help labor and delivery clinicians quickly, easily and consistently identify patients developing worsening conditions
SANTA CLARA, California, June 26, 2018 /PRNewswire/ -- Based on its recent analysis of the North American perinatal information systems market, Frost & Sullivan
Photo - https://mma.prnewswire.com/media/707180/PeriGen_Award.jpg
Multiple peer-reviewed studies indicate that more than 50% of bad outcomes in childbirth are preventable. The vast majority of them are associated with delayed recognition and response to clear warning signs. This has led to the creation of checklists designed to draw clinical attention to worsening conditions, but these checklists add significant documentation burden, and good compliance is difficult in clinical settings. PeriWatch Vigilance automates the real-time identification of patients with these warning signs, providing clinicians with standardized analysis and timely notification of troubling trends so that they can follow protocols in a more consistent and timely way. Critical data elements and trends in fetal heart rate abnormalities, maternal vital signs and labor progress are shown in a single, time-aligned view spanning several hours.
"During our 10-step selection process, PeriGen and PeriWatch Vigilance received high marks for our key innovation criteria, namely understanding clinical need, product quality and customer value," noted Nancy Fabozzi, Principal Analyst at Frost & Sullivan. "PeriWatch® Vigilance™ provides a unique collection of features to help improve the safety of childbirth. "
Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which in turn raises customer acquisition and overall market penetration potential.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol. 2015 Apr;125(4):938-47
Sadler LC, Farquhar CM, Masson VL, Battin MR. Contributory factors and potentially avoidable neonatal encephalopathy associated with perinatal asphyxia. Am J Obstet Gynecol. 2016
Report from Nine Maternal Mortality Review Committees http://reviewtoaction.org/sites/default/files/national-portal-material/Report%20from%20Nine%20MMRCs%20final%20edit.pdf
PeriGen offers innovative perinatal software solutions that incorporate artificial intelligence (AI) to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch platform to provide consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriWatch clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; follow us on Twitter, LinkedIn, YouTube, and Facebook; or call 984.208.4250 or email
Heather CaouetteAmendolaP: 508.579.3894E: email@example.com
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Ana ArriagaP: 210.247.3823F: 210.348.1003E: firstname.lastname@example.org
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All